HBM Holdings (HBM Holdings) Days Payable : 1,441.17 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Days Payable?

HBM Holdings's average Accounts Payable for the six months ended in Dec. 2023 was $15.88 Mil. HBM Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was $2.01 Mil. Hence, HBM Holdings's Days Payable for the six months ended in Dec. 2023 was 1,441.17.

The historical rank and industry rank for HBM Holdings's Days Payable or its related term are showing as below:

HBMHF' s Days Payable Range Over the Past 10 Years
Min: 2828.15 Med: 5623.62 Max: 67419.43
Current: 3216.36

During the past 6 years, HBM Holdings's highest Days Payable was 67419.43. The lowest was 2828.15. And the median was 5623.62.

HBMHF's Days Payable is ranked better than
91.29% of 723 companies
in the Biotechnology industry
Industry Median: 148.78 vs HBMHF: 3216.36

HBM Holdings's Days Payable declined from Dec. 2022 (90,783.45) to Dec. 2023 (1,441.17). It may suggest that HBM Holdings accelerated paying its suppliers.

HBM Holdings Days Payable Historical Data

The historical data trend for HBM Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Days Payable Chart

HBM Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

4,197.79

7,022.39

45,229.36

67,415.50

3,354.99

HBM Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial						22,837.14	88,092.48	90,783.45	152,454.95	1,441.17

Competitive Comparison of HBM Holdings's Days Payable

For the Biotechnology subindustry, HBM Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HBM Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Days Payable falls into.

HBM Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

HBM Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (22.029	+	15.363)	/	2 )	/	2.034	*	365
=	18.696					/	2.034	*	365
=	3,354.99

HBM Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (16.398	+	15.363)	/	2 )	/	2.011	*	365 / 2
=	15.8805					/	2.011	*	365 / 2
=	1,441.17

HBM Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

HBM Holdings (HBM Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (OTCPK:HBMHF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

02142:Hong Kong

Address

420 Fenglin Road, 12th Floor, Tower A, Fenglin International Plaza Phase II, Xuhui District, Shanghai, CHN, 200032

Website

https://www.harbourbiomed.com

HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.

HBM Holdings (HBM Holdings) Headlines

From GuruFocus

Harbour BioMed Announces Positive Profit Alert

By PRNewswire • 01-19-2024